Podcast - Children and Familial Hypercholesterolemia
Familial Hypercholesterolemia, FH for short. It is an inherited disorder that leads to aggressive and premature cardiovascular disease. In FH patients, genetic mutations makes the liver incapable of metabolizing (or removing) excess LDL (the bad kind of cholesterol). This includes problems like heart attacks, strokes, and even narrowing of our heart valves. With this series of podcasts we will learn really what FH is, how to manage it, FH and Children, and women.
View the podcast transcript (PDF)
Podcast Description
This podcast, hosted by The FH Foundation Founder and CEO Katherine Wilemon along with Pediatric Cardiologist Dr. Samuel Gidding discuss everything you need to know about Familial Hypercholesterolemia and children. Learn about when to get your child screened, and what to do if your child is diagnosed with FH.Podcast Participant Bios
Katherine Wilemon
Ms. Wilemon is the Founder and CEO of The FH Foundation. Her own journey to receive an accurate diagnosis and appropriate care for Familial Hypercholesterolemia (FH) urged her to devote her life to this cause. After being turned away from the ER several times and having a heart attack at 38, Ms. Wilemon set out to raise awareness of FH and save lives. Her goals are to reverse the shocking statistics and empower people with FH to have longer, healthier lives.Dr. Samuel Gidding
Dr. Gidding is retired but most recently served as division head of pediatric cardiology at Nemours Cardiac Center and A. I. DuPont Hospital for Children, and professor of pediatrics at Thomas Jefferson University. He is author of the AHA Scientific Statement: The Agenda for Familial Hypercholesterolemia. Dr. Gidding has practiced pediatric cardiology for over 30 years.The FH Foundation is a patient-centered nonprofit organization, dedicated to research, advocacy, and education for all forms of Familial Hypercholesterolemia (FH). Its mission is to raise awareness of FH and save lives by increasing the rate of early diagnosis and encouraging proactive treatment. If left untreated, this life-threatening genetic disorder leads to aggressive cardiovascular disease in men, women, and children of all races and ethnicities around the world. .
